Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Avista Public Acquisition Corp II Cl A (NQ: AHPA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Nov 1, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Avista Public Acquisition Corp II Cl A OmniAb Business Combination Approved by APAC Shareholders October 24, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma August 24, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Reports Second Quarter 2022 Financial Results August 08, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Reports First Quarter 2022 Financial Results May 04, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II March 23, 2022 From Ligand Pharmaceuticals Incorporated Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.